Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus

      Abstract

      Aims

      Our main aim was to analyse gender differences in the association of adherence and poor glycaemic control (PGC) in a cohort of patients with type 2 diabetes mellitus in Germany.

      Methods

      Baseline data of the DIANA-study, a prospective cohort study of type 2 diabetes mellitus patients in South-West Germany, were analysed. Information on medication adherence and factors related to PGC was obtained by self-administered questionnaire. PGC was defined as HbA1c ≥ 7.5%. Bivariate and multivariate analyses using log-binomial regression were employed to assess overall and gender-specific associations of non-adherence and PGC.

      Results

      624 men and 518 women were included in the analyses. In total, 147 men (24%) and 114 women (23%) reported non-adherence to medication. In men, PGC was found in 37% of the participants reporting non-adherence and in 19% reporting adherence (adjusted prevalence ratio (PR) = 1.90, 95%-CI: 1.46–2.49). In women, PGC was found in 19% of the participants reporting non-adherence and in 18% reporting adherence (adjusted PR = 0.97, 95%-CI: 0.65–1.46).

      Conclusions

      Our results show gender-specific differences in the association of adherence and PGC. This underlines the need for efforts to improve glycaemic control in patients with type 2 diabetes mellitus with a particular focus on men.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Hauner H.
        • Hanisch J.
        • Bramlage P.
        • Steinhagen-Thiessen E.
        • Schunkert H.
        • Jöckel K.H.
        • et al.
        Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
        Exp Clin Endocrinol Diabetes. 2008; 116: 18-25
        • King D.K.
        • Glasgow R.E.
        • Toobert D.J.
        • Strycker L.A.
        • Estabrooks P.A.
        • Osuna D.
        • et al.
        Self-efficacy, problem solving, and social-environmental support are associated with diabetes self-management behaviors.
        Diabetes Care. 2010; 33: 751-753
        • Cramer J.A.
        • Roy A.
        • Burrell A.
        • Fairchild C.J.
        • Fuldeore M.J.
        • Ollendorf D.A.
        • et al.
        Medication compliance and persistence: terminology and definitions.
        Value Health. 2008; 11: 44-47
        • Cohen H.W.
        • Shmukler C.
        • Ullman R.
        • Rivera C.M.
        • Walker E.A.
        Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).
        Diabet Med. 2010; 27: 210-216
        • Bezie Y.
        • Molina M.
        • Hernandez N.
        • Batista R.
        • Niang S.
        • Huet D.
        Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes.
        Diabetes Metab. 2006; 32: 611-616
        • Odegard P.S.
        • Capoccia K.
        Medication taking and diabetes: a systematic review of the literature.
        Diabetes Educ. 2007; 33: 1014-1029
        • Lin E.H.
        • Katon W.
        • Von Korff M.
        • Rutter C.
        • Simon G.E.
        • Oliver M.
        • et al.
        Relationship of depression and diabetes self-care, medication adherence, and preventive care.
        Diabetes Care. 2004; 27: 2154-2160
        • Nau D.P.
        • Aikens J.E.
        • Pacholski A.M.
        Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus.
        Gend Med. 2007; 4: 205-213
        • Corsonello A.
        • Pedone C.
        • Lattanzio F.
        • Lucchetti M.
        • Garasto S.
        • Carbone C.
        • et al.
        Regimen complexity and medication nonadherence in elderly patients.
        Ther Clin Risk Manag. 2009; 5: 209-216
        • Odegard P.S.
        • Gray S.L.
        Barriers to medication adherence in poorly controlled diabetes mellitus.
        Diabetes Educ. 2008; 34: 692-697
        • Grant R.W.
        • Devita N.G.
        • Singer D.E.
        • Meigs J.B.
        Polypharmacy and medication adherence in patients with type 2 diabetes.
        Diabetes Care. 2003; 26: 1408-1412
        • Mahler C.
        • Hermann K.
        • Horne R.
        • Jank S.
        • Haefeli W.E.
        • Szecsenyi J.
        Patients’ beliefs about medicines in a primary care setting in Germany.
        J Eval Clin Pract. 2012; 18: 409-413
        • Geisel-Marbaise S.
        • Stummer H.
        Diabetes adherence – Does gender matter?.
        J Public Health. 2010; 18: 219-226
        • Rivellese A.A.
        • Riccardi G.
        • Vaccaro O.
        Cardiovascular risk in women with diabetes.
        Nutr Metab Cardiovasc Dis. 2010; 20: 474-480
        • Hertz R.P.
        • Unger A.N.
        • Lustik M.B.
        Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
        Clin Ther. 2005; 27: 1064-1073
        • Ho P.M.
        • Rumsfeld J.S.
        • Masoudi F.A.
        • McClure D.L.
        • Plomondon M.E.
        • Steiner J.F.
        • et al.
        Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
        Arch Intern Med. 2006; 166: 1836-1841
        • Alvarez Guisasola F.
        • Tofe Povedano S.
        • Krishnarajah G.
        • Lyu R.
        • Mavros P.
        • Yin D.
        Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
        Diabetes Obes Metab. 2008; 10: 25-32
        • Morisky D.E.
        • Green L.W.
        • Levine D.M.
        Concurrent and predictive validity of a self-reported measure of medication adherence.
        Med Care. 1986; 24: 67-74
        • International Diabetes Federation
        Clinical Guidelines Task Force Global guideline for Type-2 Diabetes.
        International Diabetes Federation, Brussels2005
        • Craig C.L.
        • Marshall A.L.
        • Sjostrom M.
        • Bauman A.E.
        • Booth M.L.
        • Ainsworth B.E.
        • et al.
        International physical activity questionnaire: 12-country reliability and validity.
        Med Sci Sports Exerc. 2003; 35: 1381-1395
        • Ware Jr., J.
        • Kosinski M.
        • Keller S.D.
        A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.
        Med Care. 1996; 34: 220-233
        • Rubin R.R.
        Adherence to pharmacologic therapy in patients with type 2 diabeters mellitus.
        Am J Med. 2005; 118: 27S-34S
        • Lerman I.
        Adherence to treatment: the key for avoiding long-term complications of diabetes.
        Arch Med Res. 2005; 36: 300-306
        • Grant R.
        • Adams A.S.
        • Trinacty C.M.
        • Zhang F.
        • Kleinman K.
        • Soumerai S.B.
        • et al.
        Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.
        Diabetes Care. 2007; 30: 807-812
        • Schmittdiel J.A.
        • Uratsu C.S.
        • Karter A.J.
        • Heisler M.
        • Subramanian U.
        • Mangione C.M.
        • et al.
        Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
        J Gen Intern Med. 2008; 23: 588-594
        • Sarwar N.
        • Gao P.
        • Seshasai S.R.
        • Gobin R.
        • Kaptoge S.
        • Di Angelantonio E.
        Emerging Risk Factors Collaboration Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
        Lancet. 2010; 375: 2215-2222
        • Thayer S.
        • Arondekar B.
        • Harley C.
        • Darkow T.E.
        Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea.
        Ann Pharmacother. 2010; 44: 791-799
        • Rothenbacher D.
        • Rüter G.
        • Saam S.
        • Brenner H.
        Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value.
        Br J Gen Pract. 2003; 53: 389-391
        • Rozenfeld Y.
        • Hunt J.S.
        • Plauschinat C.
        • Wong K.S.
        Oral antidiabetic medication adherence and glycemic control in managed care.
        Am J Manag Care. 2008; 14: 71-75
        • Johnson N.J.
        • Backlund E.
        • Sorlie P.D.
        • Loveless C.A.
        Marital status and mortality: the national longitudinal mortality study.
        Ann Epidemiol. 2000; 10: 224-238
        • Rafalson L.
        • Donahue R.P.
        • Dmochowski J.
        • Rejman K.
        • Dorn J.
        • Trevisan M.
        Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study.
        Ann Epidemiol. 2009; 19: 365-371
        • Dirmaier J.
        • Watzke B.
        • Koch U.
        • Schulz H.
        • Lehnert H.
        • Pieper L.
        • et al.
        Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control.
        Psychother Psychosom. 2010; 79: 172-178
        • Deakin T.
        • McShane C.E.
        • Cade J.E.
        • Williams R.D.
        Group based training for self-management strategies in people with type 2 diabetes mellitus.
        Cochrane Database Syst Rev. 2005; 2: CD003417
        • Garber M.C.
        • Nau D.P.
        • Erickson S.R.
        • Aikens J.E.
        • Lawrence J.B.
        The concordance of self-report with other measures of medication adherence.
        Med Care. 2004; 42: 649-652
        • Shi L.
        • Liu J.
        • Koleva Y.
        • Fonseca V.
        • Kalsekar A.
        • Pawaskar M.
        Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.
        Pharmacoeconomics. 2010; 28: 1097-1107